0202 Amgen
BioCentury & Getty Images

Product Development

Amgen reiterates focus on protein degradation, details setbacks to four early-stage cancer programs

Feb 3, 2021 | 2:57 AM GMT

Amgen reiterated its commitment to becoming a leader in protein degradation while putting the brakes on a quartet

Read the full 496 word article

How to gain access

Continue reading with a
two-week free trial.